Donate
Call the Lung HelpLine
Ask a Question
The following text field filters the results that follow as you type. Use Tab to access the results.
  1. Home
  2. Research & Reports
  3. About Our Research
  4. Meet the Researchers
  5. Kayla Goliwas, PhD
Kayla Goliwas, PhD

Kayla Goliwas, PhD

University of Alabama at Birmingham

Research Project:
Combining Immune Checkpoint Therapy and Interlukin-6 Targeting to Enhance the Anti-Tumor Immune Response

Grant Awarded:

  • Catalyst Award

Research Topic:

  • immunology immunotherapy

Research Disease:

  • lung cancer

Treatment of non-small cell lung cancer continues to be a major clinical challenge. A new combination of therapies targeting infiltrating immune suppressive cells, which promote tumor progression, may increase the body’s anti-tumor immune response. Therefore, this treatment strategy is of great interest. This study aims to evaluate the potential to combine current clinically utilized immune directed therapy with inhibition of one pathway involved in the accumulation of immune suppressive cells within the tumor, interleukin-6 signaling, to increase therapeutic effect.

Page last updated: April 18, 2024

Asthma Educator Institute
, | Jul 11, 2015
See All Events